Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Immobilization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115466756A discloses novel immobilized transaminases for sitagliptin production. Achieve high conversion, stability, and cost reduction in pharmaceutical manufacturing.
Patent CN111686809A reveals a robust dual-enzyme system for producing chiral statin intermediates, offering enhanced stability and cost-effective manufacturing solutions.
Patent CN104774889B details a novel fructosyltransferase method for sucrose-6-acetate, offering high yield and purity for reliable supply chain integration.
Patent CN103103234A details immobilized enzyme technology for NAD production offering enhanced stability and conversion efficiency for supply chain optimization.
Patent CN118063351B reveals immobilized enzyme process for high-purity chiral beta-amino acids, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102517361A details lipase-catalyzed arbutin synthesis offering mild conditions and high purity for reliable cosmetic ingredient supply chains.
Patent CN115851694A details a novel immobilized enzyme method for synthesizing 2'-fluoro-deoxyribonucleosides, offering superior stability, reusability, and cost-effective manufacturing for antiviral intermediates.
Patent CN101899484B details a novel co-immobilization method for genipin production, offering high purity, extended enzyme stability, and significant cost reductions for supply chains.
Patent CN107858384A reveals a fusion enzyme method for L-tert-leucine. Offers high purity, thermal stability, and reusable biocatalysts for cost-effective pharmaceutical intermediate manufacturing.
Patent CN107099516B reveals a stable 7β-hydroxysteroid dehydrogenase mutant enabling high-concentration ursodeoxycholic acid synthesis with superior thermal stability and simplified downstream processing.
Patent CN105368913A reveals dual-enzyme immobilization for chiral amino acids. Offers high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN105368913A reveals dual-enzyme immobilization for high-purity chiral unnatural amino acid production with significant cost and supply chain advantages.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN106191150A details a co-immobilized enzymatic method for D-alanine. Achieves >98% purity with continuous 55-day operation, offering significant supply chain stability and cost reduction.
Patent CN112175892B reveals a novel co-expression engineering bacterium reducing PLP dependency. Discover cost-effective antibiotic intermediate manufacturing solutions.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.
Patent CN113061594A details a robust immobilized transaminase process for sitagliptin intermediates, offering superior stability and simplified solvent systems for cost-effective API manufacturing.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN114045271B reveals high-efficiency biocatalysis for Atazanavir intermediates. Discover cost reduction and supply chain reliability with immobilized enzyme technology.
Patent CN110396532A reveals enzymatic route for sialyllactose. High yield and low cost process ensures reliable supply chain for nutritional ingredients manufacturing globally.